HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Suzuki Selected Research

Adjuvant Chemotherapy

12/2023Efficacy of platinum-based adjuvant chemotherapy for epidermal growth factor receptor-mutant lung adenocarcinoma.
1/2023Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201.
1/2022Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
5/2021Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301.
7/2020A phase 2 study of adjuvant carboplatin plus S-1 followed by maintenance S-1 therapy for patients with completely resected stage II/IIIA non-small cell lung cancer-Japanese Northern East Area Thoracic Surgery Study Group JNETS1302 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyuki Suzuki Research Topics

Disease

191Neoplasms (Cancer)
04/2024 - 01/2002
42Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2023 - 07/2003
34Lung Neoplasms (Lung Cancer)
12/2023 - 01/2002
22Adenocarcinoma of Lung
12/2023 - 12/2002
21Hepatocellular Carcinoma (Hepatoma)
02/2024 - 01/2014
19Carcinoma (Carcinomatosis)
08/2023 - 01/2004
19Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
01/2023 - 06/2002
18Neoplasm Metastasis (Metastasis)
07/2023 - 09/2003
16Infections
11/2023 - 07/2005
12Carcinogenesis
10/2023 - 02/2003
11Stomach Neoplasms (Stomach Cancer)
04/2024 - 05/2003
11Colorectal Neoplasms (Colorectal Cancer)
06/2023 - 01/2004
10Hypertension (High Blood Pressure)
06/2022 - 04/2004
9Fibrosis (Cirrhosis)
12/2024 - 01/2004
8Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 03/2009
8Fever (Fevers)
11/2023 - 01/2005
8Disease Progression
11/2023 - 01/2021
8Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 06/2017
8Adenocarcinoma
07/2021 - 01/2010
7Breast Neoplasms (Breast Cancer)
04/2024 - 11/2018
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2023 - 03/2015
7Squamous Cell Carcinoma of Head and Neck
06/2023 - 03/2007
7Proteinuria
01/2023 - 11/2008
7COVID-19
06/2022 - 01/2021
7Inflammation (Inflammations)
01/2020 - 09/2002
7Nephritis
12/2019 - 11/2002
7Retinal Detachment (Retinal Detachments)
05/2017 - 01/2015
6Melanoma (Melanoma, Malignant)
03/2024 - 09/2003
6Hemorrhage
01/2024 - 01/2014
6Thrombocytopenia (Thrombopenia)
10/2022 - 06/2009
6Heart Failure
08/2020 - 10/2012
6Cardiovascular Diseases (Cardiovascular Disease)
07/2017 - 09/2004
5Retinal Perforations
06/2018 - 01/2015
5Macular Edema
01/2016 - 01/2014
4Aneurysm (Aneurysms)
01/2023 - 01/2009
4Pneumonia (Pneumonitis)
01/2023 - 01/2016
4Hypersensitivity (Allergy)
12/2022 - 01/2005

Drug/Important Bio-Agent (IBA)

44Monoclonal AntibodiesIBA
04/2024 - 06/2006
35Proteins (Proteins, Gene)FDA Link
03/2024 - 06/2002
28ErbB Receptors (EGF Receptor)IBA
12/2023 - 09/2005
25Immune Checkpoint InhibitorsIBA
01/2024 - 09/2016
23Immunoglobulin G (IgG)IBA
04/2024 - 02/2005
23Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2014
19LigandsIBA
01/2024 - 09/2004
12AntibodiesIBA
04/2024 - 06/2002
12Bevacizumab (Avastin)FDA Link
04/2024 - 03/2009
10AntigensIBA
02/2024 - 02/2005
10Formaldehyde (Formol)FDA Link
08/2023 - 11/2014
10Phosphotransferases (Kinase)IBA
01/2021 - 10/2005
9human ERBB2 proteinIBA
04/2024 - 12/2021
9ParaffinIBA
08/2023 - 06/2017
9Intravenous Immunoglobulins (IVIG)FDA Link
01/2023 - 12/2003
9NivolumabIBA
01/2023 - 09/2016
9Angiotensin IIIBA
01/2011 - 10/2005
9Transforming Growth Factor beta (TGF-beta)IBA
05/2010 - 11/2002
8Glycoproteins (Glycoprotein)IBA
03/2024 - 11/2018
8CytokinesIBA
01/2022 - 06/2004
8Retinaldehyde (Retinal)IBA
01/2021 - 01/2016
7Tyrosine Kinase InhibitorsIBA
11/2023 - 10/2018
7Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2023 - 10/2011
7Immunoglobulins (Immunoglobulin)IBA
01/2023 - 07/2005
7B7-H1 AntigenIBA
01/2023 - 12/2020
7VaccinesIBA
01/2022 - 01/2012
6G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
04/2024 - 04/2022
6Trastuzumab (Herceptin)FDA Link
04/2024 - 09/2022
6ChemokinesIBA
04/2024 - 04/2022
6Amino AcidsFDA Link
03/2024 - 01/2019
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 11/2003
5PlatinumIBA
12/2023 - 07/2003
5LDL Lipoproteins (beta Lipoproteins)IBA
12/2023 - 04/2010
5Peptides (Polypeptides)IBA
04/2023 - 02/2005
5COVID-19 VaccinesIBA
01/2023 - 01/2021
5SteroidsIBA
01/2023 - 01/2016
5Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 12/2019
5Sorafenib (BAY 43-9006)FDA Link
10/2022 - 01/2014
5EnzymesIBA
11/2021 - 10/2010
5Cisplatin (Platino)FDA LinkGeneric
05/2021 - 07/2003
4Amino Acid Transport Systems (Amino Acid Transporter)IBA
02/2024 - 01/2019
4oxidized low density lipoproteinIBA
12/2023 - 04/2010
4lenvatinibIBA
10/2023 - 04/2020
4Protein Isoforms (Isoforms)IBA
06/2023 - 05/2022
4Epithelial Cell Adhesion MoleculeIBA
02/2023 - 06/2022
4CateninsIBA
01/2023 - 03/2021
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
12/2022 - 04/2022
4pembrolizumabIBA
10/2022 - 09/2018
4Anaplastic Lymphoma KinaseIBA
10/2022 - 01/2016
4Prednisolone (Predate)FDA LinkGeneric
10/2022 - 09/2003

Therapy/Procedure

90Therapeutics
12/2024 - 01/2002
35Drug Therapy (Chemotherapy)
12/2023 - 03/2007
26Immunotherapy
02/2024 - 03/2009
10Radiotherapy
04/2023 - 11/2008
9Renal Dialysis (Hemodialysis)
11/2023 - 09/2002
8Vitrectomy
01/2017 - 01/2015
7Aftercare (After-Treatment)
02/2023 - 03/2005
5Extracorporeal Membrane Oxygenation
01/2024 - 01/2016
5Adjuvant Chemotherapy
12/2023 - 07/2020
5Operative Surgical Procedures
07/2023 - 03/2008
5Pneumonectomy (Lung Volume Reduction)
12/2019 - 01/2002
4Blood Component Removal (Apheresis)
12/2023 - 01/2017
4Lymph Node Excision (Lymph Node Dissection)
11/2022 - 07/2003